相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Probiotics and constipation: mechanisms of action, evidence for effectiveness and utilisation by patients and healthcare professionals
Eirini Dimidi et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2020)
Using probiotics for type 2 diabetes mellitus intervention: Advances, questions, and potential
Zhongke Sun et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2020)
The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review
Dominika Jakubczyk et al.
NUTRIENTS (2020)
Therapeutic effects of Lactobacillus paracasei subsp. paracasei NTU 101 powder on dextran sulfate sodium-induced colitis in mice
Chien-Li Chen et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2019)
Tetrandrine inhibits differentiation of proinflammatory subsets of T helper cells but spares de novo differentiation of iTreg cells
Huimin Zou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance
Qinglin Li et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2019)
Effect of Probiotics Supplementations on Health Status of Athletes
Bhagavathi Sundaram Sivamaruthi et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine
Manoj Kumar et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Homeobox protein Hhex negatively regulates Treg cells by inhibiting Foxp3 expression and function
Sung Woong Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial
Cesare Cremon et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Anticancer and Antimigration Effects of a Combinatorial Treatment of 5-Fluorouracil and Lactobacillus paracasei subsp paracasei NTU 101 Fermented Skim Milk Extracts on Colorectal Cancer Cells
Chia-Yuan Chang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)
Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation
Zhao-Hua Shen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Lactobacillus paracasei ssp paracasei YBJ01 reduced D-galactose-induced oxidation in male Kuming mice
Huayi Suo et al.
JOURNAL OF DAIRY SCIENCE (2018)
Mucosal Immunity Related to FOXP3+ Regulatory T Cells, Th17 Cells and Cytokines in Pediatric Inflammatory Bowel Disease
Jinhee Cho et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2018)
Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation
Minesh Mehta et al.
INNATE IMMUNITY (2017)
Commercial Probiotic Products: A Call for Improved Quality Control. A Position Paper by the ESPGHAN Working Group for Probiotics and Prebiotics
Sanja Kolacek et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Probiotics: From Isolation to Application
Parisa Shokryazdan et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2017)
Fermented milk containing Lactobacillus paracasei subsp paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride
Elisabet Sanchez et al.
SCIENTIFIC REPORTS (2017)
A consumer's guide for probiotics: 10 golden rules for a correct use
Marco Toscano et al.
DIGESTIVE AND LIVER DISEASE (2017)
The Potential Role of Probiotics in Cancer Prevention and Treatment
Ai-Qun Yu et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2016)
The global burden of IBD: from 2015 to 2025
Gilaad G. Kaplan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease
M. Friedrich et al.
MUCOSAL IMMUNOLOGY (2015)
Modulation of Fecal Clostridiales Bacteria and Butyrate by Probiotic Intervention with Lactobacillus paracasei DG Varies among Healthy Adults
Chiara Ferrario et al.
JOURNAL OF NUTRITION (2014)
Cytokine IL-6 is required in Citrobacter rodentium infection-induced intestinal Th17 responses and promotes IL-22 expression in inflammatory bowel disease
Lei Li et al.
MOLECULAR MEDICINE REPORTS (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
CD4+ T-cell subsets in intestinal inflammation
Matthew Shale et al.
IMMUNOLOGICAL REVIEWS (2013)
A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome
Wolfgang Kruis et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2012)
Safety assessment of probiotics for human use
Mary Ellen Sanders et al.
GUT MICROBES (2010)
In vivo effects of mesalazine or E-coli Nissle 1917 on microsatellite instability in ulcerative colitis
A. Goel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
W Kruis et al.
GUT (2004)